$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
服用瑞格非尼需要定期检测肝肾功能、血常规
2025-10-19 11:44:20
Check Details
瑞格非尼治疗经治结直肠癌患者的预后临床因素:对临床管理的影响
2025-10-19 11:44:20
Check Details
瑞格非尼+支架植入治疗伴重度气道狭窄的重症肺腺癌
2025-10-19 11:44:20
Check Details
经治结直肠癌患者服用瑞格非尼治疗的预后临床因素:对临床管理的影响
2025-10-19 11:44:20
Check Details
瑞格非尼服用期间,定期检测肝肾功能
2025-10-19 11:44:20
Check Details
瑞格非尼在日本实体瘤患者中的I期安全性及疗效研究
2025-10-19 11:44:20
Check Details
难治性转移性结直肠癌的真实世界治疗模式和结果
2025-10-19 11:44:20
Check Details
瑞格非尼成功治疗神经纤维瘤-胃肠道间质瘤
2025-10-19 11:44:20
Check Details
托法替尼治疗溃疡性结肠炎患者
2025-10-19 11:44:20
Check Details
曲美替尼+达拉非尼+化疗治疗BRAF V600E转移性结肠腺癌
2025-10-19 11:44:20
Check Details
瑞戈非尼治疗直肠癌的说明书
2025-10-19 11:44:20
Check Details
瑞格非尼在晚期结直肠癌治疗中的应用
2025-10-19 11:44:20
Check Details
1
2
...
1590
1591
1592
1593
1594
1595
1596
...
4153
4154
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
2
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
3
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
4
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
5
Complete Guide to Dosage and Dose Adjustment of Entrectinib
6
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
7
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
8
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
9
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
10
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
11
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
12
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety